HuGE Literature Finder
Records 1-10
|
A donor and recipient candidate gene association study of allograft loss in renal transplant recipients receiving a tacrolimus-based regimen.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2018 Apr . Woillard Jean-Baptiste, Gatault Philippe, Picard Nicolas, Arnion Hélène, Anglicheau Dany, Marquet Pier |
|
Association of CYP3A4*1B genotype with Cyclosporin A pharmacokinetics in renal transplant recipients: A meta-analysis.
Gene 2018 Apr . Wang Cai-E, Lu Ke-Peng, Chang Zhao, Guo Meng-Li, Qiao Hai-Li |
|
Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the femoral head in Chinese population.
Molecular biology reports 2014 May 41 (5): 3135-46. Zhang Yanqiong, Kong Xiangying, Wang Rongtian, Li Shangzhu, Niu Yanfang, Zhu Liuluan, Chen Weiheng, Lin |
|
Genetic differences in native americans and tacrolimus dosing after kidney transplantation.
Transplantation proceedings 2013 Jan 45 (1): 1. Chakkera HA, Chang YH, Bodner JK, Behmen S, Heilman RL, Reddy KS, Mulligan DC, Moss AA, Khamash H, Katariya N, Hewitt WR, Pitta TL, Frassetto LA |
|
Single-nucleotide polymorphisms, acute rejection, and severity of tubulitis in kidney transplantation, accounting for center-to-center variation.
Transplantation 2010 Dec 90 (12): 1401-8. Israni Ajay, Leduc Robert, Holmes John, Jacobson Pamala A, Lamba Vishal, Guan Weihua, Schladt David, Chen Jinbo, Matas Arthur J, Oetting William S, |
|
Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
Therapeutic drug monitoring 2009 Dec 31 (6): 734-42. Musuamba Flora Tshinanu, Mourad Michel, Haufroid Vincent, Delattre Isabelle Karine, Verbeeck Roger Karel, Wallemacq Pier |
|
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009 Jun 48 (11): e108-16. Rodríguez-Nóvoa Sonia, Labarga Pablo, Soriano Vincent, Egan Deirdre, Albalater Marta, Morello Judit, Cuenca Lorena, González-Pardo Gema, Khoo Saye, Back David, Owen Andr |
|
Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation.
The pharmacogenomics journal 2008 Aug 8 (4): 248-55. Woodahl E L, Hingorani S R, Wang J, Guthrie K A, McDonald G B, Batchelder A, Li M, Schoch H G, McCune J |
|
CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients.
Clinical pharmacology and therapeutics 2007 Dec 82 (6): 711-25. Kuypers D R J, de Jonge H, Naesens M, Lerut E, Verbeke K, Vanrenterghem |
|
Effect of MDR1 gene polymorphism on progression of end-stage renal disease.
Acta pharmacologica Sinica 2007 Apr 28 (4): 579-83. Zhang Wei-xia, Chen Bing, Zhang Wen, Chen Nan, Yu Zi-cheng, Cai Wei-m |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 18, 2020
- Content source: